通知公告
Peking University School of Basic Medical Sciences Postdoctoral Researcher Recruitment
The School of Basic Medical Sciences at Peking University (Beijing, China) has been a cornerstone of excellence in basic medical education and research since its establishment in 1954. Today, it stands as a premier institution in China, comprising 16 departments (institutes), national key laboratories, and multiple internationally recognized research bases and technological platforms. Renowned for its exceptional faculty and dynamic academic environment, the school boasts 6 academicians of the Chinese Academy of Sciences and Chinese Academy of Engineering, 20 recipients of the National Science Fund for Distinguished Young Scholars, and a Nobel laureate among its distinguished alumni. Each year, faculty and researchers publish over 400 high-impact scientific papers, with groundbreaking work featured in top-tier journals such as Science, Nature, Cell, NEJM and Nature Medicine.
With a growing roster of world-class principal investigators, we are actively seeking talented young scientists to launch their academic careers at the Peking University School of Basic Medical Sciences. We are dedicated to cultivating a collaborative, inclusive, and innovative research environment that drives transformative discoveries and fosters academic excellence.
Who We’re Looking For:
Postdoctoral Opportunities
We are seeking highly motivated and talented postdoctoral researchers to join our vibrant research community. Opportunities are available across over 40 laboratories in four cutting-edge research areas (links or website):
Cardiometabolic & Cerebrovascular Sciences
Neuroscience & Cognitive Disorders
Infectious Diseases & Immunological Therapeutics
Oncology, Cellular Dynamics & Aging Research
What We Offer:
- Very competitive salary and benefits packages.
- Access to state-of-the-art research facilities and resources.
- Opportunities for professional development and career advancement.
- A vibrant and supportive research community.
Application Process:
Interested candidates should submit the following documents to [email address]:
1. A cover letter outlining your research interests and career goals.
2. A detailed curriculum vitae (CV).
3. Contact information for three referees.
4. All applicants should be under 35 years old at the time of application (born after January 1, 1990)
Contact Information:
Contact Person: Li Wang
Office Phone: +86-10-82801684
Email: wangli@bjmu.edu.cn
Address: Peking University Health Science Center
38 Xueyuan Road, Haidian District, Beijing, China 100191
Appendix: Discipline-Specific Postdoctoral Recruitment Details
Cardiometabolic and Cerebrovascular Sciences
Wei Kong, M.D., Ph.D.
Professor, Dean of the School of Basic Medical Science, and Chair of the Department of Physiology and Pathophysiology at Peking University Health Science Center.
Research Associate, University of Washington, 2001
Postdoctoral Research Fellow, New York University School of Medicine, 2003
Research Directions: ECM and GPCR in Vascular Diseases
The Kong Laboratory research investigates the regulation of microenvironment in vascular homeostasis and diseases (atherosclerosis, vascular calcification, and aortic aneurysms/dissections), particularly focusing on the role of the extracellular matrix (ECM) and G Protein Coupled Receptors (GPCRs). The laboratory has published over 150 papers in journals such as Nature, Nature Reviews Cardiology, Circulation, and European Heart Journal. Professor Kong is an Associate Editor for American Journal of Physiology-Cell Physiology and serves on the editorial boards of Circulation Research and Matrix Biology. She has received prestigious awards, including the Bill Gates Foundation Innovation Challenge Award (2016) and Joseph Loscalzo Best Basic/Translational Research Paper of the Year Award from the American Heart Association (2023). She is also a Fellow of the International Society for Heart Research.
Position available: Postdoc
Contact information: kongw@bjmu.edu.cn
Lab website: https://physiology.bjmu.edu.cn/kxyj/js/c55c470b170d42839bac1e853f851042.htm
Changtao Jiang
Changtao Jiang, Ph.D., is a tenured full professor at Peking University, serving as the deputy dean of the School of Basic Medical Sciences. He is the recipient of The National Science Fund for Distinguished Young Scholars and XPLORER PRIZE. His work aims at gut microbiota, microbial enzymes and their impact on metabolic diseases. He proposed a novel theory of “cross-species regulation of host homeostasis by gut microbial enzymes” a new concept of “microbial-host isozymes”. He has published more than 30 SCI papers in: Science (2025a, 2025b, 2023), Nature (2025, 2022), Cell (2024), Nature Medicine (2019, 2018, 2017), Cell Metabolism (2024, 2021a, 2021b, 2019), Cell Host & Microbe (2024), Nature Microbiology (2024), Nature Metabolism (2024a, 2024b) and other journals, among which, 9 papers are highly cited papers, one paper is picked up by F1000Research and 11 papers are highlighted and internationally recognized by scholars in the field. He is also invited to serve on the editorial board of Cell Metabolism. He has obtained Top 10 Chinese life scientific advances (2024 and 2023), Ten major scientific and technological progress of China's colleges and Universities (2023) and First prize of Beijing Science and Technology (the first finisher).
Position available: Postdoctor
Contact information: jiangchangtao@bjmu.edu.cn
Li Qiang, Ph.D.
Professor and Chair, Department of Pharmacology (since 2024)
B.S. Peking University (2001)
Ph.D. Boston University (2007)
Assistant Professor, Columbia University, 2015
Associate Professor with tenure, Columbia University, 2022
Research Directions: Metabolism and Aging
The Qiang Laboratory is dedicated to unraveling the shared mechanisms underlying obesity and aging from both systemic and translational perspectives, with the ultimate goal of extending human healthspan with improved safety. Our research focuses on three primary areas: (1) the noncanonical functions of IgG in aging and obesity, (2) the role of protein posttranslational modifications (PTMs) of PPARγ in determining transcriptional selectivity, and (3) metabolic tissue-specific drug delivery and targeting. Our recent discoveries have been published in leading journals such as Cell Metabolism (2023,2024, 2025), Nature Nanotechnology (2022), Advanced Science (2023), Journal of Hepatology (2020), Journal of Clinical Investigation (2018), and ACS Nano (2017, which received the highest attention score of the year).
Position available: Postdoc and graduate students
Contact information: qiang@pku.edu.cn
https://scholar.google.com/citations?hl=en-US&user=85Ly28EAAAAJ
Liheng Wang, Ph.D.
Principle Investigator, Institute of Cardiovascular Sciences (since 2023)
Associate professor, Department of Physiology and Pathophysiology, Peking University Health Science Center
Education and working experience
B.S. China Agricultural University (2003-2007)
Ph.D. Columbia University (2009-2015)
Post-doc Columbia University (2015-2022)
Assistant Professor Icahn School of Medicine at Mount Sinai (2022-2023)
Research Directions: Regulation of glucose and lipid metabolism
The Wang Laboratory focuses on the mechanistic studies on regulation of glucose and lipid metabolism, particularly the pathogenesis of chronic diseases such as obesity, diabetes, fatty liver diseases and aging. Dr. Wang has published 20 papers in leading metabolic journals including Cell, Cell Metabolism, Journal of Hepatology, JCI et al. My major findings including: 1) Developed the first in vitro human stem cell model for studying the genetic obesity syndromes; 2) Systematically identified transcription factors involved in the regulation of hepatic glucose metabolism, leading to the discovery of novel pathogenic factors for Type 2 Diabetes (TOX4) and Non-Alcoholic Steatohepatitis (PU.1); 3) Revealed Immunoglobulin G (IgG) as a driving factor for both obesity and aging, demonstrating its role in modulating the decline of metabolic function associated with insulin resistance, chronic inflammation and aging. She is a recipient of several prestigious awards, including the NIH Career Development Award (K01), Regeneron Fellowship, New York Diabetes Center Scientific Exploration Award, a National Youth Talent Award. She has been invited to deliver oral presentations at notable international and domestic conferences, including Keystone Symposia, Cold Spring Harbor Asia Meetings, the Chinese American Diabetes Association Annual Meeting, the Chinese American Liver Association Annual Meeting, and the Chinese Biophysical Society Metabolism Section Annual Meeting.
Position available: Postdoc and graduate students
Contact information: lihengwang@hsc.pku.edu.cn
https://scholar.google.com/citations?user=FHp6pI0AAAAJ&hl=en
Yue YIN, Ph.D.
Assistant Professor, Department of Pharmacology
B.S. Peking University (2013)
Ph.D. Peking University (2016)
Lecturer, Peking University, 2016
Assistant Professor, Peking University, 2021
Research Directions: Endocrine Pharmacology
The Yin Lab focuses on the gut-liver crosstalk and its impact on MASLD (metabolic dysfunction-associated steatotic liver disease) from the perspective of the heterogeneity of intestinal absorption epithelial cells and novel gut/bacterial derived factors. Major achievements include: 1) Revealing new mechanisms of entero-liver crosstalk: the preferential differentiation of intestinal absorption epithelium and epithelium-derived exosomes regulate the occurrence and development of MASLD. 2) Defining a novel hormonal crosstalk between the stomach and liver. Gastric endocrine cells can sense the overall energy levels to alter MASLD. With the support of NSFC, CAST and Beijing Nova Program, 15 papers were published as the first/corresponding author in the past 5 years such as Nature Communications (2), Acta Pharmaceutica Sinica B, EBioMedicine (2), eLife, FASEB J, and Life Metabolism. Editorial comments on our findings have been published in prestigious journals.
Position available: Postdoc and graduate students
Contact information: yueyin@bjmu.edu.cn
https://mp.weixin.qq.com/s/0a8dH9Ab3IlbB-HO5Aznwg
Junhua Zhou, Ph.D.
Associate Professor, Department of Physiology and Pathophysiology (since 2022)
Bachelor of Clinical Medicine: Guangzhou Medical University (2007)
Master in Internal Medicine: Peking University (2010)
PhD in Medicine: University of Cambridge (2016)
Postdoctoral Research: University of Cambridge and Queen Mary University of London (2016-2021)
Research Directions: Adrenal Gland Disorders
The Zhou Laboratory is dedicated to elucidate the underlying pathophysiological mechanisms of adrenal gland disorders, with the ultimate goal of developing therapeutic strategies to enhance adrenal health in patients. Our research focuses on two primary areas: (1) Pathophysiology of adrenal-source hypertension and precision medicine, (2) Adrenal development, pathophysiology, and regeneration. Our recent discoveries have been published in leading journals such as Nature Genetics and Hypertension. We maintain robust partnerships with affiliated hospitals and are committed to bridging the gap between research discoveries and clinical implementation.
Position available: Postdoc and graduate students
Contact information: junhua.zhou@pku.edu.cn
Yiting Jia, Ph.D.
Assistant Professor, Department of Pharmacology (since 2023)
B.S. Peking University，School of Basic Medical Sciences (2015)
Ph.D. Peking University，Department of Physiology (2018)
Postdoc. Peking University，Department of Physiology & Pathophysiology (2022)
R.A. Peking University，Department of Physiology & Pathophysiology (2023)
Research Directions: Cardiovascular Pharmacology
The Jia Laboratory has maintained a long-standing focus on investigating cellular metabolism and regulatory mechanisms in vascular microenvironments. In recent years, we have conducted systematic research on vascular cellular sensing and regulation during pathological processes: (1) The metabolic shift from mitochondrial oxidative phosphorylation to glycolysis has been identified as a critical early driver of smooth muscle cell (SMC) phenotypic switching and the pathogenesis of atherosclerosis-related diseases. Our work revealed endogenous molecular pathways that counteract vascular remodeling by inhibiting pathological metabolic reprogramming in SMCs. (Circ Res. 2022; Circulation 2021; Cell Death Dis. 2018). (2) Lysosomal sensing of metabolic homeostasis through TFEB/TFE3 activation has been established as a crucial regulatory mechanism for macrophage polarization. This finding enabled us to identify naringenin, a natural compound, as a potential therapeutic agent for abdominal aortic aneurysm. (Cell Discov. 2022; ATVB. 2017)
Position available: Postdoc and graduate students
Contact information: yitingjia@bjmu.edu.cn
Complete List of Published Work:
https://www.ncbi.nlm.nih.gov/myncbi/yiting.jia.1/bibliography/public/
Jing Zhou, Ph.D.
Professor, Department of Physiology and Pathophysiology, Peking University
B.S. Chongqing University (2001)
Ph.D. Chongqing University (2006)
Postdoctoral Scholar, the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2006-2009)
Postdoctoral Scholar, National Health Research Institute (2009)
Postdoctoral Scholar, University of California (UC), San Diego (2009-2011)
Assistant Project Scientist, University of California (UC), San Diego (2011-2014)
Assistant Professor, Peking University Health Science Center (2014)
Associate Professor with Tenure, Peking University Health Science Center (2020)
Professor, Peking University Boya Distinguished Professor, Peking University Health Science Center (2024)
Research Directions: Mechanobiology and Cardiovascular Diseases
The Zhou Laboratory is committed to advancing research in the following key areas: 1) Investigating the mechanisms that govern the communication between the mechanical microenvironment and cells within blood vessel walls, both in vivo and in vitro, as well as exploring potential therapeutic drugs and intervention techniques. 2) Discovering and characterizing novel mechanosensory receptor molecules and elucidating their mechanisms for sensing mechanical stimuli. 3) Studying the regulatory processes that maintain vascular function and homeostasis, and exploring the pathogenesis of vascular diseases, such as atherosclerosis, along with potential intervention strategies.
Position available: Postdoc
Contact information: jzhou@pku.edu.cn
https://scholar.google.com/citations?user=bEl5lckAAAAJ&hl=zh-CN
ORCID: 0000-0002-2211-4901
Qiaoxia Zheng, Ph.D.
Researcher, Department of Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center
B.S. Xiangya School of Medicine, Central South University (2004-2008)
M.S. Institute of Zoology, Chinese Academy of Sciences (2008-2012)
Ph.D. Peking University (2013-2018)
Assistant Researcher, Institute of Biophysics, Chinese Academy of Sciences, 2018-2022
Associate Researcher, Institute of Biophysics, Chinese Academy of Sciences, 2023-2024
Researcher, Department of Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center, 2024-Present.
Research Directions: spatiotemporal calcium signaling and its role in the pathophysiological functions of organelles
Calcium ions (Ca²⁺), as multifunctional secondary messengers, regulate a variety of physiological processes. Ca²⁺ signaling in living organisms is highly diverse, with significant spatiotemporal variations in local concentrations and dynamics across different tissues, organs, cells, extracellular environments, cytoplasm, and various organelles, as well as their localized microenvironments. Ca²⁺ signals are transduced through Ca²⁺-binding effector proteins or by phosphorylating downstream molecules via various Ca²⁺-dependent and Ca²⁺/calmodulin-dependent protein kinases (CDPKs or CaMKs). Ca²⁺ signaling is highly dynamic and exhibits complex spatiotemporal distribution patterns. In resting cells, a steep transmembrane [Ca²⁺] gradient of tens of thousands of times is established between the cytoplasm and organelles such as the endoplasmic reticulum and lysosomal membranes. The formation of these transmembrane concentration gradients relies on the precise regulation of Ca²⁺ channels, pumps, and exchangers. Due to the actions of these Ca²⁺ regulatory proteins, unique Ca²⁺ signaling submicrodomains are formed during the transmembrane influx and efflux of Ca²⁺. These localized Ca²⁺ signaling submicrodomains serve as critical sites for the function or activation of many proteins, enzymes, and kinases. Our group focuses on spatiotemporal Ca²⁺ signaling, exploring the dynamic changes of Ca²⁺ in specific nanodomains within the endoplasmic reticulum, lysosomes, cell membrane, mitochondria, and other intracellular localized spaces, as well as their roles in physiological and pathological processes.
Our recent discoveries have been published in leading journals such as Cell (2016, 2022, which was awarded as one of the "Top 10 Advances in Life Sciences in China for 2022."), Molecular Cell (2025), Development Cell, Journal of Cell Science, Nature Communications, Hypertension.
Position available: Postdoc and graduate students
Contact information: zhqiaoxia@bjmu.edu.cn
https://sbms.bjmu.edu.cn/jsdw/bssds/Qiaoxia_Zheng.html
https://physiology.bjmu.edu.cn/kxyj/js/c9bb60b34151493bbb3744781fc769dd.htm
Weizhen Zhang, PhD, is a professor of Physiology at Peking University Health Science Center. Dr. Zhang has published over 180 peer-reviewed papers in prestigious journals such as PNAS, Hepatology, Nature Communication, Ebiomedicine, Diabetes, Diabetologia. Dr. Zhang serves as the ad hoc reviewer for over 30 peer-reviewed journals such as Gut, Nat Commun, Endocrinology and Int J Obs, editorial board members of 6 peer-reviewed journals, and standing members of grant review committees such as NSFC, ADA, Diabetes UK, BBSRC. Dr. Zhang’s research focuses on defining the mechanisms that underlie fuel sensing in the gastrointestinal endocrine cells and how the fuel sensor in the GI tract coordinates the organism energy status to control glucose and lipid metabolism.
Position available: Postdoc and graduate students
Contact information: weizhenzhang@bjmu.edu.cn
Xin Cong, Ph.D.
Associate Professor, Department of Physiology and Pathophysiology
B.S. Peking University Health Science Center (2007)
Ph.D. Peking University Health Science Center (2012)
Post. Doc. Peking University Health Science Center (2014)
Associate Professor, Peking University Health Science Center, since 2017
Research Directions: Regulation of Intercellular Tight Junctions
Considering that structural and functional integrity of endothelial and epithelial barrier is an indispensable factor to maintain the homeostasis of the body, the Cong Laboratory has carried out a series of work focusing on the functional and regulatory mechanism of intercellular tight junctions including: (1) to uncover the novel function characteristics and regulatory mechanism of endothelial or epithelial tight junctions; (2) to develop the detection method of tight junction function in animals in vivo; (3) to develop novel noninvasive warning probes and drugs for vascular diseases based on the detection and enhancement of tight junction function, respectively. Our discoveries have been published in European Heart Journal (2023, with editorial), Hypertension (2023), International Journal of Oral Science (2025, 2022), Arthritis Rheumatology (2022), Journal of Dental Research (2024, 2023, 2020, 2017, 2016, one paper as cover story), Journal of Cell Science (2015, 2013, one paper recommended by F1000), etc.
Position available: Postdoc and graduate students
Contact information: congxin@bjmu.edu.cn
Neuroscience and Cognitive Disorders Division
Yun Wang, Ph.D., Professor
Department of Neurobiology, School of Basic Medical Sciences, PKU
McGovern Institute for Brain Research, PKU
Institute of Advanced Clinical Medicine, PKU
Research Directions: Pain Coding, Neural Development and Brain Diseases
The Wang Laboratory dedicated to advancing our understanding of pain coding mechanisms in both the peripheral and central nervous systems, as well as exploring pain-related comorbidities, and investigating the mechanisms of neural development, injury repair, and brain diseases. Our ultimate mission is to develop innovative strategies for nerve regeneration, pain relief, and the treatment of neurodevelopmental disorders. Our research focuses on three key areas: (1) Identifying molecular mechanisms and neural circuits that underlie chronic pain and pain-related emotional disorders. (2) Unraveling signal transduction pathways involved in neural development, injury, and neurodegenerative diseases. Our groundbreaking discoveries have been published in leading peer-reviewed journals, including Molecular Psychiatry, Nature communications, Science signaling, Cell reports, Advanced Science and Journal of Neuroscience. Through these efforts, we committed to translating our findings into impactful clinical applications that improve the lives of individuals suffering from pain and neurological disorders.
Position available: Postdoc and graduate students
Contact information: wangy66@bjmu.edu.cn
Website: https://nri.bjmu.edu.cn/jgydw/js/28f4a8a0a4234be79a53093aaab36141.htm
Guo-Gang Xing, Ph.D.
Professor, Vice director, Neuroscience Research Institute, Peking University; Department of Neurobiology, School of Basic Medical Sciences, Peking University Health Sciences Center; Key Laboratory for Neuroscience, Ministry of Education of China & National Health Commission of China.
38 Xue-Yuan Road, Hai-Dian District, Beijing 100191, China.
Phone: 86 (0)10 82805842
Email: ggxing@bjmu.edu.cn
Academic experience
Guo-Gang Xing earned his Ph.D. Degree in Xi'an Jiaotong University in 2001, and then received post-doctoral trainings in the Neuroscience Research Institute of Peking University, the Sanford Burnham Prebys (SBP) Medical Research Institute, and the University of Wisconsin-Madison in USA (2001-2006). Dr. Xing joined the Neuroscience Research Institute of Peking University as an associate professor of neurobiology in 2004 and professor in 2013.
Research interests
(1) Molecular mechanisms of chronic pain
To elucidate the initiation, development and maintenance of chronic pain, to investigate the roles of receptors and ion channels, key molecules and signaling pathways in the pathogenesis of chronic pain, and the neurocircuitry mechanisms of chronic pain.
To illuminate the neural mechanisms underlying the comorbid anxiety and depression symptoms in chronic pain.
(2) Stem cells and neurodevelopmental disorders
To explore the molecular mechanisms underlying the pathogenesis of neurodevelopmental disorders using human induced pluripotent stem cells (iPSCs) and human brain organoids.
Research techniques
Multi-disciplinary approaches and techniques are utilized in Dr. Xing’s lab, which include molecular biology, cell biology, morphology, behavioral pharmacology, metabonomics, RNA-sequencing, single-cell sequencing, iPSCs, genome editing, calcium imaging, epigenetics, optogenetics, chemogenetics, and electrophysiology such as in vivo extracellular recording, patch-clamp recording, and in vivo multichannel recording in awake, free-moving animals.
Fundings
Dr. Xing’s researches are supported by the grants from National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, National Key Research and Development Program of China, National Basic Research Program of China (973 Program), and Special Fund of Industry Special Fund of Ministry of Health.
Publications
Dr. Xing’s research has been published in Advanced Materials, Molecular Psychiatry, Cell Communication and Signaling, Brain Behavior and Immunity, Journal of Neuroinflammation, The Journal of Neuroscience, Pain, and Science Signaling, which are top journals in the field of research.
Position available: Postdoc and research assistant.
Contact information: ggxing@bjmu.edu.cn
Laboratory website
https://nri.bjmu.edu.cn/jgydw/ktzjj/ae8bc3cb78c444bcaa9e60332c89602b.htm
Cheng CEN, Ph.D. Associate Professor
Department of Neurobiology, School of Basic Medical Sciences, PKU
Neuroscience Research Institute, PKU
B.S. Huazhong University of Science and Technology (2010)
Ph.D. Peking University (2015)
Research Directions: Central mechanisms of pain and its intervention
My research is focused on elucidating the central mechanisms of pain coding across diverse pathological conditions, as well as exploring the intricate interplay between pain and emotional-cognitive behaviors. Our research is centered on three key areas: (1) the neural circuits in the brain that underlie pain processing and their dysregulation in various disease states, (2) the heterogeneity and plasticity of specific neuronal clusters involved in pain perception, and (3) the role of neuropeptides in the modulation and regulation of pain. Through these investigations, we aim to advance our understanding of pain pathophysiology and identify novel therapeutic targets. Our recent discoveries have been published in leading journals including Science signaling, Nature communications, and Journal of neuroscience.
Position available: Postdoc and graduate students
Contact information: cencheng418@bjmu.edu.cn
Website: https://nri.bjmu.edu.cn/jgydw/js/94fbad07fe794e98b0e40683f80a3366.htm
Fan Mei, Ph.D.
Assistant Professor, Department of Neurobiology
B.S. Peking University (2008)
Ph.D. Peking University (2011)
Visiting Fellow National Institutes of Health, NIH (2010)
Lecture Peking University Health Science Center (2024)
Assistant Professor Peking University Health Science Center (since 2025)
Research Directions: Alzheimer’s disease
Dr. Mei’s research focuses on the functional study of genetic risk factors of Alzheimer’s disease (AD) and characterizes the mechanism underlying AD pathophysiology. We interpret the coding and non-coding AD-associated variants from whole-genome sequencing of AD cohorts. The main research efforts are categorized into three primary areas: (1) AD susceptibility, (2) AD pathophysiology, and (3) cholinergic dysregulation and memory decline in AD. Our recent discoveries have been published in Nature Communications (2024), Cell Research (2024), EMBO Reports (2023), BMC Medicine (2023), Cell Reports (2022, 2017).
Position available: Postdoc
Contact information: meifan@hsc.pku.edu.cn
Hong Jiang, Ph.D.
Tenure-Track Assistant Professor/Principle Investigator, Neuroscience Research Institute, Department of Neurobiology, Peking University (since 2022)
M.D Zheng Zhou University, China (2003-2008)
Ph.D. Peking University, China (2008-2014)
Postdoctoral Fellow, Max Planck Institute for Metabolism Research, Germany (2015-2022)
Research Directions: Metabolism and Sleep
The Jiang Laboratory is committed to uncovering the shared mechanisms that regulate sleep-wake homeostasis and its interaction with metabolism. Using cutting-edge techniques including closed-loop EEG/EMG sleep recording, in vivo and ex vivo electrophysiology, and advanced spatial and single-cell transcriptomics, we focus on hypothalamic neurocircuitry to understand how lifestyle factors contribute to sleep disorders and obesity, and how these conditions exacerbate each other. Our ultimate goal is to identify novel therapeutic strategies for future treatments. Our recent work has been published in leading journals such as Neuron, Cell Metabolism, Journal of Neuroscience, Cell Reports.
Position available: Postdoc and graduate students
Contact information: hong.jiang@hsc.pku.edu.cn
Jie Zheng, Ph.D.
Assistant Professor, Department of Medical Neurology (since 2022)
Post.doc Huazhong University of Science and Technology (2016-2020)
Ph.D. Peking University (2012-2016)
B.S. Huazhong University of Science and Technology (2008-2012)
Research Directions: Neurodegeneration and neurogenesis
Zheng’s lab seeks to restore neurodegeneration in the brain under Alzheimer's disease (AD), the main cause of dementia in the elderly. We use a range of techniques to: (1) investigate pathological mechanisms underlying tau-involved neurodegeneration and cell senescence during the onset and progression of AD, (2) develop novel chimeric drugs targeting tau and other key protein factors, (3) explore pro-neurogenic remedies and cell therapy for AD and related tauopathies. Our recent discoveries have been published in journals such as Cell Stem Cell (2020), Signal Transduct Target Ther. (2021), Aging Cell (2024), Science Bulletin (2024), Cell Chemical Biology (2024).
Position available: Postdoc and graduate students
Contact information: zhengjiie@hsc.pku.edu.cn
https://www.x-mol.com/groups/zhengjiie?lang=en
Linlin Sun, Ph.D.
Assistant Professor, Department of Neuroscience
Contact information: linlin.sun@pku.edu.cn
https://scholar.google.com/citations?hl=en&user=PzXwHVcAAAAJ
B.S. Peking University (2005.9 – 2010.6)
Ph.D. Peking University (2010.9 – 2013.6)
Postdoc, Rutgers University (2013.10 – 2016.6)
Postdoc, New York University (2016.7 – 2018.4)
Postdoc, Columbia University (2018.5 – 2020.11)
The Sun lab studies neural mechanisms for pain and drug addiction (1) Investigating DRG mechanisms involved in abnormal somatosensation and their role in regulating internal organs under both physiological and pathological conditions. (2) Exploring brain circuitry to understand social and memory impairments in drug addiction. Our recent discoveries have been published in Nature Communications (2019, 2023), PNAS (2022), Advanced Science (2020).
Position available: Postdoc
Applicants with expertise in neuroscience, circuitry dissection, computational methods and DRG-related backgrounds are highly desirable. However, the lab is open to motivated and enthusiastic individuals who are willing to explore unfamiliar research areas.
Ming Yi, Ph.D.
Principal Investigator, Neuroscience Research Institute
B.M. Peking University Health Science Center (2002)
Ph.D. University College London (2009)
Research Directions: Decoding, manipulating and reconstructing memory
Learning and memory are crucial cognitive functions for daily life, whereas pathological memories underlie a variety of neuropsychiatric diseases such as post-traumatic stress disorder and chronic pain. Yi laboratory, with combinative application of in vivo and in vitro electrophysiology, two-photon calcium imaging, opto- and chemo-genetics and molecular biology, focuses on decoding, manipulating and reconstructing memory and other brain functions, and aims to develop novel assessment and intervention tools for various neuropsychiatric disorders. Our research focuses on three primary areas: (1) neuronal basis and functional reconstruction of the memory system; (2) neuronal and circuitry basis of pain memory; and (3) Assessment and rehabilitation of brain injuries in infants and children. Our recent discoveries have been published in leading journals such as Nature Communications (2024), Science Advances (2020), Cell Reports (2019, 2022, 2023), Autophagy (2024), Medical Image Analysis (2024), PLoS Biology (2024), etc.
Position available: Postdoc and graduate students
Contact information: mingyi@hsc.pku.edu.cn
Rong Zhang, Ph.D.
Associate Professor, Department of Neurobiology (since 2012)
B.S. Shanxi Medical University (1996-2001)
Ph.D. Fudan University (2001-2006)
Lecture, Peking University, 2006
Associate Professor, Peking University, 2012
Research Directions: Etiology of autism, Translational Medicine of Acupuncture related technology
Dr. Zhang has engaged in autism-related basic and clinical research and acupuncture translation medicine for 19 years. She has undertaken a number of national and provincial-level projects and international cooperation projects, and published more than 90 in-depth articles, including 73 SCI, which have been cited over 1,700 times in total with a H-Index of 21. In the field of autism, the research results have obtained 3 invention patent, 1 domestic utility model patent, and 1 copyright of the scale and commercial transformed successfully. As one of the initiators, she established the Autism Research Center of Peking University Health Science center, and served as Routine Vice President of Beijing Society of Neuroscience (BJSN), Ninth, Tenth Committee member of Beijing science and Technology Association, and organized several autism international forums and public welfare activities.
Position available: Postdoc and graduate students
Contact information: zhangrong@bjmu.edu.cn
Siyuan Zhao, Ph.D.
Assistant Professor, Peking University Health Science Center
Email: siyuanzhao@hsc.pku.edu.cn
Education
B.S., Shandong University, 2010-2014
Ph.D., Peking University, 2014-2019
Postdoctoral Fellow, Harvard University, 2019-2024
Academic Appointments
Assistant Professor, Peking University Health Science Center, 2024–present
Research Interests
The Zhao Lab is focused on engineering soft materials and flexible bioelectronics to tackle fundamental challenges in neuroscience and biomedical engineering. Our long-term goal is to enhance human performance through next-generation brain-computer interfaces (BCIs). Our research areas include:
Soft and Flexible Neural Interfaces – Developing ultraflexible, biocompatible devices for seamless integration with neural tissue.
Long-term Stable Neural Recording and Modulation – Designing strategies for chronic, high-fidelity neural interfacing with minimal immune response.
Neural Decoding – Leveraging advanced signal processing and machine learning to interpret neural signals and understand brain function.
Recent research findings have been published in Nature Nanotechnology (2024), Nature Neuroscience (2023), Nature Electronics (2023), and Nature Communications (2020).
Open Positions
We are currently recruiting postdoctoral researchers and graduate students who are passionate about flexible electronics, neural engineering, and brain-machine interfaces. Please reach out via email with your CV and a brief statement of research interests.
Yong Zhang, Ph.D.
Associate Professor with tenure, Department of Neurobiology
B.S. Shandong University (1999)
Ph.D. Johns Hopkins University (2009)
Research Directions: AMPA receptor plasticity and related brain disorders
Learning and memory is fundamental for human cognition and behavior. AMPA receptors (AMPARs) mediate the majority of fast excitatory synaptic transmission in the central nervous system. The dynamic process of AMPA receptor insertion and removal from the synapses plays a crucial role in synaptic plasticity and learning and memory. The Zhang Lab focus on elucidating neural mechanisms underlying learning and memory and pathology of learning related brain disorders such as Alzheimer’s disease and Depression, which is essential for understanding brain function in both health and disease. Our recent discoveries have been published in leading journals such as PNAS (2021,2023), Neuron (2020), Nature Cell Biology (2018).
Positions available: Postdoctoral fellows and graduate students
Contact information: yongzhang@hsc.pku.edu.cn
https://scholar.google.com/citations?user=79K9E8gAAAAJ&hl=en
Lin Lu, M.D., Ph.D.
Academician of Chinese Academy of Sciences
Professor and Director of the Peking University Institute of Mental Health/Peking University Sixth Hospital
Research Directions: Sleep disorders and Psychiatry
Prof. Lu's laboratory primarily focuses on the neurobiological mechanisms and interventions for psychiatric disorders, spanning both animal models and human subjects. These disorders include substance use disorders, post-traumatic stress disorder (PTSD), insomnia, and depression. The present research investigates (1) the neural substrates involved in dynamic pathological memory, developing novel memory consolidation and reconsolidation interference procedures to erase pathological drug and fear memories, (2) the intricate role of gut microbiota in insomnia, conducting translational research in individuals diagnosed with insomnia disorder, (3) a new strategy for treating psychiatric disorders during sleep. He has published over 400 peer-reviewed articles in journals such as Science and The Lancet, with over 35,000 citations (H-index: 90).
Position available: Postdoc and graduate students
Contact information: linlu@bjmu.edu.cn
Jie Shi, M.D., Ph.D.
Professor and Executive Director, National Institute on Drug Dependence, Peking University
Research Directions: Cognitive Science and Psychiatry
Prof. Shi is a holder of the National Science Fund for Distinguished Young Scholars, Boya Distinguished Professor of Peking University, and Chief Scientist of the Major Project of the China Brain Initiative. Prof. Shi’s research focuses on the neural mechanisms and interventions of drug addiction and related psychiatric disorders such as sleep and depressive disorders: 1) neural and genetic imaging mechanisms and interventions of addiction; 2) brain functional regulation and mechanisms of sleep-wake cycles; 3) neural mechanisms and interventions of depression. She has published over 240 high-level research articles on Science, JAMA Psychiatry, Am J Psychiatry, Brain Behav Immun, Sci Adv, Mol Psychiatry, Biol Psychiatry, and other top journals in this field. With these achievements, Prof. Shi won the 1st prize of the Outstanding Achievement Award for Scientific Research in Higher Education Institutions (Natural Science Award), the 1st and 2nd prize of the Chinese Medical Science and Technology Award, and the Wu Jieping-Paul Janssen Medical & Pharmaceutical Award, etc.
Position available: Postdoc and graduate students
Contact information: shijie@bjmu.edu.cn
Ying Han, Ph.D.
Assistant professor | Doctoral supervisor
Peking University Health Science Center
EDUCATION
09/2008 – 07/2013 Bachelor degree in basic medicine, Peking University
09/2013 – 07/2016 Ph.D. in neuropsychopharmacology, Peking University
PROFESSIONAL EXPERIENCE
08/2016 – 07/2019 National Institute on Drug Dependence, Peking University, assistant research fellow
08/2019 – 04/2024 National Institute on Drug Dependence, Peking University, assistant professor, associate research fellow, doctoral supervisor
05/2024 – present National Institute on Drug Dependence, Peking University, assistant professor, research fellow, doctoral supervisor
RESEARCH INTERESTS: Stress and psychiatric disorders
Using animal models (such as chronic unpredictable stress, social defeat stress, social isolation, learned helplessness, sleep deprivation and self-administration et al.), combined with behavioral, molecular, pharmacological, psychological, and neuroimaging techniques, my laboratory mainly focuses on investigating the neural mechanisms that underlie stress-induced abnormal behaviors with the goal of discovering new targets for rapid antidepressant action and novel therapeutic interventions for stress-related psychiatric disorders. Our recent discoveries have been published in leading journals such as Science Bulletin, Science Advances, Molecular Psychiatry, Sleep Medicine Reviews, and Brain Behavior and Immunity, and so on, among which five were recognized as a highly cited article at Web of Science, and the achievements are highly appraised by peers.
Position available: Postdoc and graduate students
Contact information: yinghan@bjmu.edu.cn
Infectious Diseases and Immunological Therapeutics
Fuping You, Ph.D.
Tenured Associate Professor and Chair, Department of Pathogenic Biology
2006-2011 PhD in Cell biology, college of life science, Peking University.
2011-2013 Postdoctoral Associate, Section of infectious disease, Internal Medicine, Yale school of medicine.
2013-2014 Associate Research Scientist, Section of infectious disease, Internal Medicine, Yale school of medicine.
2014-2021 Assistant Professor in Peking University Health Science Center, China.
2019-present Deputy director, Institute of Systems Biomedicine, Peking University.
2021-present Tenured Associate Professor in Peking University Health Science Center, China.
2024-present Chair, the Department of Pathogenic Biology,Peking University.
Research Directions: anti-viral and anti-tumor innate immunity
The You Laboratory is dedicated to unraveling the shared mechanisms how pattern recognition regulates innate immunity and cell death, as well as their functional and molecular mechanisms during antiviral responses and tumorigenesis, to provide theoretical foundations and therapeutic targets for related diseases. Our recent discoveries have been published in leading journals such as Cell, Nature Immunology, Cell Host & Microbe, Nature Nanotechnology, Cell Research, Genome Biology, EMBO Reports, Science Signaling, and Cell Reports.
Position available: Postdoc and graduate students
Contact information: fupingyou@pku.edu.cn
Kuanhui Xiang, Ph.D.
Assistant Professor, Department of Microbiology and Infectious Disease Center (since 2022)
B.S. Hebei Medical University (2011)
Ph.D. Peking University (2017)
Lecturer, Peking University, 2017
Assistant Professor, Peking University, 2022
Research Directions: virus and host interaction
The Xiang Laboratory is dedicated to unraveling the mechanisms underlying host broad-spectrum antiviral strategy, with the ultimate goal of developing broad-spectrum antiviral drugs. Our research focuses on elucidating the role of interferon stimulated genes in innate immunity with broad implications for the treatment of viral infections (such as: HBV cell permissiveness and cccDNA formation) and related pathogenesis like liver disease. Our recent discoveries have been published in leading journals such as J Hepatol (2016), STTT(2020), J Adv Res(2022), Stem Cell Rep.(2022), Antivir Res (2022).
Position available: Postdoc and graduate students
Contact information: kxiang@bjmu.edu.cn
https://scholar.google.com/citations?user=W_mzaMUAAAAJ&hl=en
Kai Wang
Kai Wang, Ph.D., is an associate researcher at Peking University, Department of Immunology. He is the recipient of The National Science Fund for Excellent Youth Scholars. His work aims at gut fungi and immune homeostasisHe has published more than 10 SCI papers in: Cell (2024), Science (2023), Nature (2022), Cell Metabolism (2021), Cell Reports (2019) and other journals, among which, 5 papers are highly cited papers, one paper is picked up by F1000Research. He has obtained Top 10 Chinese life scientific advances (2024 and 2023), Ten major scientific and technological progress of China's colleges and Universities (2023) and First prize of Beijing Science and Technology (the fourth finisher).
Position available: Postdoctor
Contact information: wangkai@bjmu.edu.cn
Hui Dai, Ph.D.
Associate Professor, Department of Immunology
B.S. Peking University, 2003
Ph.D. Peking University, 2008
Assistant Professor, Peking University, 2008
Associate Professor, Peking University, 2016
Research Directions: Glycoimmunology and Tumor immunity
The Dai Laboratory focuses on glycans in immune regulation and disease pathogenesis, particularly in autoimmunity and cancer. Key directions include: 1) Identifying immunological active glycostructures using glycoproteomics and NMR; 2）Investigating glycan-mediated immune mechanisms through receptor signaling and epigenetic studies; 3) Characterizing anti-glycan antibodies' roles in disease progression and treatment. Recent findings in glycoimmunology have been published in The Lancet Microbe, Journal of Autoimmunity, Biomaterials, Bone Research, Cellular & Molecular Immunology, Journal of Immunology, and Protein & Cell.
Position available: Postdoc and graduate students
Contact information: daihui@bjmu.edu.cn
Oncology, Cellular Dynamics and Aging Research Cluster
Jianyuan Luo, Ph.D.
Professor and Chair, Department of Medical Genetics (since 2024)
B.S. Peking University (1986)
M.S. Peking University (1990)
Ph.D. University of Kentucky (1999)
Associate Research Scientist, Columbia University, 2002-2003
Assistant Professor, University of Massachusetts Medical School, 2003-2010
Associate Professor, University of Maryland, 2010-2015
Professor, Peking University, 2015-present
Haiying Wang, Ph.D.
Associate professor, Department of Biochemistry and Molecular Biology
B.S. Inner Mongolia Minzu University (1996)
M.S. Shenyang Agricultural University (1999)
Ph.D. China Agricultural University (2002)
Lecturer, Peking University, 2002-2008
Associate professor, Peking University, 2008-present
Research Directions: Post-translational protein modification
The Luo and Wang Laboratory is dedicated to uncovering the molecular mechanisms of aging and cancer through the lens of protein post-translational modifications, with the ultimate vision of extending human lifespan. Our research centers around three key areas:
1.Deciphering the intricate mechanisms of epigenetic regulation in cancer initiation and progression.
2.Exploring how protein post-translational modifications drive both cancer development and aging processes.
3.Investigating DNA damage repair mechanisms and their implications for cancer development and therapy.
By unraveling these molecular pathways, we aim to identify novel therapeutic targets and interventions that could revolutionize how we approach aging and cancer in clinical settings. Our recent discoveries have been published in leading journals such as Nat Commun (2024), Proc Natl Acad Sci U S A (2024), EMBO Rep (2023), Cell Death Differ (2023), Cell Death Dis (2023), and Cell Rep (2022).
Position available: Postdoc
Contact information: luojianyuan@bjmu.edu.cn, wendy@bjmu.edu.cn
Dr. Libin Wang, Assistant Professor
Department of Cell Biology, School of Basic Medical Sciences, Peking University
Dr. Wang carried out his PhD research with Prof. Qi Zhou on cellular reprogramming and imprinted gene function at the Institute of Zoology, Chinese Academy of Science. After earning his PhD, Dr. Wang continued his postdoctoral research on developing novel chromosome engineering technology under the mentorship of Prof. Wei Li and Prof. Qi Zhou at the same institute. Dr. Wang successfully engineered whole-chromosome fusion in mouse haploid embryonic stem cells, generating animals with one fewer chromosome pair. His groundbreaking work published in Science demonstrated the feasibility of chromosome-level engineering in mammals.
Research Directions
In 2023, Dr. Wang established his own research group at Peking University. Leveraging cutting-edge expertise in chromosome engineering and stem cell technologies, the Wang Lab conducts pioneering research in:
(1) Generating innovative animal models of human chromosomal disorders to investigate underlying mechanisms and develop novel therapeutic approaches.
(2) Developing novel technologies to tackle outstanding key challenges in eukaryotic chromosome engineering.
Position available
We are recruiting a postdoc researcher with relevant expertise in chromosome engineering and/or stem cell research. The candidate should have a strong track record of productive research, demonstrated by publications or submitted manuscripts.
Full Publication List: https://www.sciencedirect.com/author/57208610044/libin-wang
Contact information: wanglibin@bjmu.edu.cn
Tian Lu, Ph.D.
Assistant Professor, Department of Biochemistry and Molecular Biology (since 2024)
B.S. Peking University (2011)
Ph.D. Harvard University (2015)
Postdoc. Harvard University (2022)
Research Directions: Spatial multi-omics
Epigenomic regulation plays a crucial role in genome architecture, transcription, and metabolism, closely intertwining with tissue organization. The Lu Laboratory develops novel spatial multi-omics tools to decode epigenomic regulation at both the cellular and tissue levels, aiming to drive innovations in early diagnosis, intervention strategies, and personalized medicine.
Our research focuses on three key areas:
1. Advancing spatiotemporal single-cell multi-omics tools to capture dynamic molecular processes with high precision.
2. Developing imaging-based CRISPR screens to identify key regulators of molecular organization.
3. Applying spatial multi-omics to uncover disease mechanisms in embryonic development, cancer, and cardiovascular disease.
Our recent discoveries have been published in leading journals such as Cell, and PNAS.
Position available: Postdoc and graduate students
Contact information: tianlu@bjmu.edu.cn
Lab Website: https://www.x-mol.com/groups/tianlu_lab
Wenjian Bi, Ph.D.
Assistant Professor, Department of Medical Genetics
B.S. Sichuan University (2006-2010)
Ph.D. Academy of Mathematics and Systems Sciences, Chinese Academy of Sciences (2010-2015)
PostDoc Researcher, St. Jude Children’s Research Hospital, 2015-2018
PostDoc Researcher, University of Michigan, 2018-2021
Assistant Professor, Peking University, 2021 until now
Research Directions: Statistical Genetics, Systems Biology
The Bi Laboratory mainly focuses on statistical genetics and biostatistics. He has developed some fast and accurate approaches for large-scale biobank data analysis. (1) GWAS algorithm for complex trait including categorical phenotype, time-to-event data, longitudinal data, and imaging data, (2) GWAS algorithm for admixture population and family-relatedness for complex trait, and (3) computational efficient and powerful gene-environment interaction algorithm for GWAS. Our recent discoveries have been published in leading journals such as Nature Genetics, (2022), American Journal of Human Genetics (2019, 2020, 2021, 2023), Nature Communications (2025a, 2025b, 2025c), and PLOS Genetics (2024).
Position available: Postdoc and graduate students
Contact information: wenjianb@pku.edu.cn
Website: https://www.x-mol.com/groups/wenjianb
Yang Liu, Ph.D.
Principal investigator
Assistant Professor, Department of Medical Genetics
B.S. Beijing Normal University (2011)
Ph.D. Peking University (2017)
Assistant Professor, School of Basic Medical Sciences, Peking University (2024)
Research Interests: DNA replication regulation and genome stability maintenance
DNA replication ensures the faithful transmission of genetic information from parents to offspring, and its dysregulation leads to genome instability that contributes to various human diseases, including cancer, infertility, and early embryonic developmental defects. The Liu Laboratory is dedicated to elucidating the mechanisms governing DNA replication within the complex chromatin environment and their critical role(s) in maintaining genome stability, which remains poorly understood. Our research focuses on three primary areas: (1) developing innovative high-throughput sequencing assays driven by fundamental scientific questions, (2) investigating the interplay between DNA replication and other crucial chromatin processes, such as transcription and the 3D genome structure, and (3) linking DNA replication-associated genome instability to human diseases, with a particular interest in infertility and early embryonic developmental defects. Our recent findings have been published in leading journals, including Science (2024), Nature Genetics (2023), PNAS (2021), Nature Communications (2024), Genome Biology (2021), and Trends in Genetics (2025).
Position available: Postdoc and graduate students
Contact information: liu.y@pku.edu.cn
https://scholar.google.com.hk/citations?user=uQRwaUMAAAAJ&hl=zh-CN
Luyang Sun, Ph.D.
Professor and Deputy Chair, Department of Biochemistry and Molecular Biology
B.S. Tianjin Medical University Bachelor (2004)
Ph.D. Peking University Health Science Center (2009)
Lecturer, Peking University Health Science Center, 2009
Associate Professor, Peking University Health Science Center, 2012
Professor, Peking University Health Science Center, 2018~
Research Directions: Epigenetic Regulation of Gene Transcription
The Sun Laboratory deciphers covalent histone modifications (ubiquitination, lactylation) as dynamic regulators of gene transcription, and drug resistance in cancers, particularly hematologic malignancies. Integrative approaches include:
Enzymatic regulation of histone modifications in cancer progression and drug resistance
Discovery of novel epigenetic factors and transcription factors mediating cellular adaptation
Multi-omics integration (epigenomics, quantitative proteomics) with structural biology and high-throughput screening to decode transcriptional networks
Recent Publications:
Cell Metabolism, Molecular Cell, Nature Communications, PNAS, Nucleic Acids Research, Genes & Development, EMBO Reports
Position Available: Postdoc and graduate students
Contact information: luyang_sun@pku.edu.cn
https://sbms.bjmu.edu.cn/jsdw/bssds/Luyang_Sun.html
Peipei Zhang, Ph.D.
Assistant Professor, Department of Biochemisty and Molecular Biology (since 2021)
B.S. Huazhong Agriculture University (2005)
Ph.D. National Institute of Biological Sciences & Beijing Normal University (2009)
Postdoctoral Research Associate, St. Jude Children’s Research Hospital (2014)
Research Directions: Stress Granules and Neurodegenerative Diseases
The Zhang Laboratory focuses on elucidating the molecular mechanisms regulating stress granules and phase separation, leveraging these insights to investigate the pathogenesis of ALS and other neurodegenerative diseases. Dr. Zhang has published 20 papers, including 11 as the first or corresponding author (or co-author with equal contribution), in high-impact journals such as Cell, eLife, Nature Communications, and Cell Reports. Furthermore, Dr. Zhang has successfully led multiple research projects funded by the National Natural Science Foundation of China, the Beijing Nova Program, and the Beijing Natural Science Foundation.
Position available: Postdoc and graduate students
Contact information: Peipei.zhang@pku.edu.cn
Kailong Li, Ph.D.
Assistant Professor, Department of Biochemistry and Molecular Biology (since 2021)
B.S. Wuhan University (2010)
Ph.D. Peking Union Medical College (2015)
Postdoctoral Fellow The University of Texas Southwestern Medical Center (2020)
Research Directions: Epigenetic regulation and editing
The Li Laboratory is dedicated to investigate the epigenetic mechanisms that control cancer and other disorders. Ongoing studies include: 1. Development and application of novel CRISPR-based epigenome editors 2. Epigenetic regulation in cancer progression and metastasis 3. Epigenetics of host-pathogen interactions. Our recent discoveries have been published in leading journals such as Cancer Discovery (2024, 2020), Science Advances (2024), Nature Communications (2020,2018),
Nucleic Acids Research (2025) etc.
Lab website: https://www.x-mol.com/groups/kailong_li_lab?lang=en.
Position available: Postdoc and graduate students
Contact information: kailongli@pku.edu.cn
Guangxi Wang, Ph.D.
Assistant Professor, Institute of Systems Biomedicine
B.S. Peking University (2013)
Ph.D. Peking University (2016)
Assistant Researcher, Chinese PLA General Hospital, 2016
Postdoctoral fellow, Peking University, 2019
Assistant Professor, Peking University, 2022
Research Directions: Metabolism, multi-omics, AI and Cancer
The Wang Laboratory uses machine learning combined with metabolomics and multi-omics as the main means to find new tumor biomarkers; combined with tumor molecular biology to develop new tumor detection and intervention methods.Our research focuses on Tumor system biomedicine and tumor molecular biology with two primary direction: 1) Discover new tumor detection methods, screening biomarkers and potential diagnostic and therapeutic targets based on metabolomics, multi-omics and machine learning; 2) Explore the application of artificial intelligence medicine in tumors and various diseases.Our recent discoveries have been published in leading journals such as Science Translational Medicine (Highly cited paper; Commentaries and editorials from Nat. Rev. Cli. Onco., 2022), Cell Research, and Science Advances.
Position available: Postdoc and graduate students
Contact information: guangxiwang@bjmu.edu.cn
https://sbms.bjmu.edu.cn/jsdw/bssds/Guangxi_Wang.html